Literature DB >> 20663882

Phosphorylation of tau at Thr212, Thr231, and Ser262 combined causes neurodegeneration.

Alejandra D Alonso1, John Di Clerico, Bin Li, Christopher P Corbo, Maria E Alaniz, Inge Grundke-Iqbal, Khalid Iqbal.   

Abstract

Abnormal hyperphosphorylation of the microtubule-associated protein Tau is a hallmark of Alzheimer disease and related diseases called tauopathies. As yet, the exact mechanism by which this pathology causes neurodegeneration is not understood. The present study provides direct evidence that Tau abnormal hyperphosphorylation causes its aggregation, breakdown of the microtubule network, and cell death and identifies phosphorylation sites involved in neurotoxicity. We generated pseudophosphorylated Tau proteins by mutating Ser/Thr to Glu and, as controls, to Ala. These mutations involved one, two, or three pathological phosphorylation sites by site-directed mutagenesis using as backbones the wild type or FTDP-17 mutant R406W Tau. Pseudophosphorylated and corresponding control Tau proteins were expressed transiently in PC12 and CHO cells. We found that a single phosphorylation site alone had little influence on the biological activity of Tau, except Thr(212), which, upon mutation to Glu in the R406W background, induced Tau aggregation in cells, suggesting phosphorylation at this site along with a modification on the C-terminal of the protein facilitates self-assembly of Tau. The expression of R406W Tau pseudophosphorylated at Thr(212), Thr(231), and Ser(262) triggered caspase-3 activation in as much as 85% of the transfected cells, whereas the corresponding value for wild type pseudophosphorylated Tau was 30%. Cells transfected with pseudophosphorylated Tau became TUNEL-positive.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20663882      PMCID: PMC2945578          DOI: 10.1074/jbc.M110.110957

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Microtubule associated protein tau binds to double-stranded but not single-stranded DNA.

Authors:  Q Hua; R Q He; N Haque; M H Qu; A del Carmen Alonso; I Grundke-Iqbal; K Iqbal
Journal:  Cell Mol Life Sci       Date:  2003-02       Impact factor: 9.261

2.  Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction.

Authors:  M Pérez; J M Valpuesta; M Medina; E Montejo de Garcini; J Avila
Journal:  J Neurochem       Date:  1996-09       Impact factor: 5.372

3.  Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly.

Authors:  B L Goode; P E Denis; D Panda; M J Radeke; H P Miller; L Wilson; S C Feinstein
Journal:  Mol Biol Cell       Date:  1997-02       Impact factor: 4.138

4.  Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease.

Authors:  Thomas Fath; Jochen Eidenmüller; Roland Brandt
Journal:  J Neurosci       Date:  2002-11-15       Impact factor: 6.167

5.  Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.

Authors:  Jean C Augustinack; Anja Schneider; Eva-Maria Mandelkow; Bradley T Hyman
Journal:  Acta Neuropathol       Date:  2002-01       Impact factor: 17.088

Review 6.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

7.  Conformational changes specific for pseudophosphorylation at serine 262 selectively impair binding of tau to microtubules.

Authors:  Daniela Fischer; Marco D Mukrasch; Jacek Biernat; Stefan Bibow; Martin Blackledge; Christian Griesinger; Eckhard Mandelkow; Markus Zweckstetter
Journal:  Biochemistry       Date:  2009-10-27       Impact factor: 3.162

8.  Phosphorylation of microtubule-associated protein tau on Ser 262 by an embryonic 100 kDa protein kinase.

Authors:  S M Jenkins; G V Johnson
Journal:  Brain Res       Date:  1997-09-05       Impact factor: 3.252

9.  Analysis of tau phosphorylation and truncation in a mouse model of human tauopathy.

Authors:  Patrice Delobel; Isabelle Lavenir; Graham Fraser; Esther Ingram; Max Holzer; Bernardino Ghetti; Maria Grazia Spillantini; R Anthony Crowther; Michel Goedert
Journal:  Am J Pathol       Date:  2007-12-13       Impact factor: 4.307

10.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

View more
  69 in total

1.  Activation of Glycogen Synthase Kinase-3 Mediates the Olfactory Deficit-Induced Hippocampal Impairments.

Authors:  Juan Hu; He-Zhou Huang; Xiang Wang; Ao-Ji Xie; Xiong Wang; Dan Liu; Jian-Zhi Wang; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2014-11-05       Impact factor: 5.590

2.  Cnga2 Knockout Mice Display Alzheimer's-Like Behavior Abnormities and Pathological Changes.

Authors:  Ao-Ji Xie; En-Jie Liu; He-Zhou Huang; Yu Hu; Ke Li; Youming Lu; Jian-Zhi Wang; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2015-09-16       Impact factor: 5.590

3.  Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau.

Authors:  Mohammad Arif; Jianshe Wei; Qi Zhang; Fei Liu; Gustavo Basurto-Islas; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  J Biol Chem       Date:  2014-08-15       Impact factor: 5.157

Review 4.  Tau-induced neurodegeneration: mechanisms and targets.

Authors:  Cindy Beharry; Leah S Cohen; Jing Di; Kawsar Ibrahim; Susan Briffa-Mirabella; Alejandra del C Alonso
Journal:  Neurosci Bull       Date:  2014-04-15       Impact factor: 5.203

Review 5.  JNK Signaling: Regulation and Functions Based on Complex Protein-Protein Partnerships.

Authors:  András Zeke; Mariya Misheva; Attila Reményi; Marie A Bogoyevitch
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

Review 6.  The structure and phase of tau: from monomer to amyloid filament.

Authors:  Yifan Zeng; Jing Yang; Bailing Zhang; Meng Gao; Zhengding Su; Yongqi Huang
Journal:  Cell Mol Life Sci       Date:  2020-10-19       Impact factor: 9.261

7.  mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease.

Authors:  Andrés Norambuena; Horst Wallrabe; Lloyd McMahon; Antonia Silva; Eric Swanson; Shahzad S Khan; Daniel Baerthlein; Erin Kodis; Salvatore Oddo; James W Mandell; George S Bloom
Journal:  Alzheimers Dement       Date:  2016-09-29       Impact factor: 21.566

8.  Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer disease.

Authors:  Zhi Tang; Erika Bereczki; Haiyan Zhang; Shan Wang; Chunxia Li; Xinying Ji; Rui M Branca; Janne Lehtiö; Zhizhong Guan; Peter Filipcik; Shaohua Xu; Bengt Winblad; Jin-Jing Pei
Journal:  J Biol Chem       Date:  2013-04-12       Impact factor: 5.157

9.  Microtubule-associated protein tau in bovine retinal photoreceptor rod outer segments: comparison with brain tau.

Authors:  Akio Yamazaki; Yuji Nishizawa; Isao Matsuura; Fumio Hayashi; Jiro Usukura; Vladimir A Bondarenko
Journal:  Biochim Biophys Acta       Date:  2013-05-24

10.  Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease.

Authors:  Gustavo Basurto-Islas; Julie Blanchard; Yunn Chyn Tung; Jose R Fernandez; Michael Voronkov; Maxwell Stock; Sherry Zhang; Jeffry B Stock; Khalid Iqbal
Journal:  Neurobiol Aging       Date:  2014-06-17       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.